Search Trials
Conditions
Learn
About

Data source: ClinicalTrials.gov

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL) | MicrobiomeTrials

← Back to trials

NCT07726771

Evaluation of the Ileo-anal Pouch in FAP (ENDOPOL)

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-07-09Est. Completion: 2031-07-09

Enrollment target: 50 participants

Locations

St Mark's Hospital Polyposis Registry (St Mark's Centre for Familial Intestinal Cancer), London, London, United Kingdom

Contact

Andrew Latchford, MBBS PhD FRCPandrew.latchford@nhs.net +442088643232

Benjamin Zare, MBChB (Hons) MRCPb.zare@nhs.net +442088643232

Other microbiome trials you might be interested in

An Open-Label, Phase 1b Trial to Assess the Safety and Efficacy of ST316 in Participants With Familial Adenomatous Polyposis (FAP)Phase 1Recruiting

Familial Adenomatous Polyposis (FAP)

This is a Phase 1b, open- label, dose-optimization study evaluating ST316 in adult participants with familial adenomatou…

Multiple LocationsEst. completion Dec 31, 2028

View Trial →

FOG-001 in Locally Advanced or Metastatic Solid TumorsPhase 1Recruiting

CancerColorectal CancerSolid TumorLocally Advanced Solid TumorMetastatic CancerWNT PathwayHCCDesmoidMicrosatellite Stable Colorectal CancerMetastatic Castration-resistant Prostate CancerFamilial Adenomatous Polyposis (FAP)Endometrial CarcinomaProstate CancerMicrosatellite Instability-High Colorectal CancerAdamantinomatous Craniopharyngioma

The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced o…

Phoenix, United StatesEst. completion Apr 1, 2027

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.